Global Tuberculosis Diagnostics and Treatment Market Size, Status and Forecast 2020-2026
- Report Code : SMA1862658
- Published On: Jul, 2020
- Category : Machinery & Equipment
- Pages : 125
-
This report focuses on the global Tuberculosis Diagnostics and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis Diagnostics and Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc
Market segment by Type, the product can be split into
Skin Testing
Laboratory Testing
Market segment by Application, split into
Hospital
Clinic
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Tuberculosis Diagnostics and Treatment status, future forecast, growth opportunity, key market and key players.
To present the Tuberculosis Diagnostics and Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Tuberculosis Diagnostics and Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
-
With tables and figures helping analyze worldwide Global Tuberculosis Diagnostics and Treatment market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Report Overview1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Skin Testing
1.4.3 Laboratory Testing1.5 Market by Application
1.5.1 Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other1.6 Coronavirus Disease 2019 (Covid-19): Tuberculosis Diagnostics and Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Tuberculosis Diagnostics and Treatment Industry
1.6.1.1 Tuberculosis Diagnostics and Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tuberculosis Diagnostics and Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tuberculosis Diagnostics and Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions2.1 Tuberculosis Diagnostics and Treatment Market Perspective (2015-2026)
2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Regions
2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Diagnostics and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Diagnostics and Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 20193.3 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Diagnostics and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2021-2026)
5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application (2015-2026)5.1 Global Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2021-2026)
6 North America6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
6.2 Tuberculosis Diagnostics and Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
7 Europe7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
7.2 Tuberculosis Diagnostics and Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
8 China8.1 China Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
8.2 Tuberculosis Diagnostics and Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
9 Japan9.1 Japan Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
9.2 Tuberculosis Diagnostics and Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
10 Southeast Asia10.1 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
10.2 Tuberculosis Diagnostics and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
11 India11.1 India Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
11.2 Tuberculosis Diagnostics and Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
12 Central & South America12.1 Central & South America Tuberculosis Diagnostics and Treatment Market Size (2015-2020)
12.2 Tuberculosis Diagnostics and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020)
13 Key Players Profiles13.1 Cepheid Inc
13.1.1 Cepheid Inc Company Details
13.1.2 Cepheid Inc Business Overview and Its Total Revenue
13.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
13.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020))
13.1.5 Cepheid Inc Recent Development13.2 Becton Dickinson
13.2.1 Becton Dickinson Company Details
13.2.2 Becton Dickinson Business Overview and Its Total Revenue
13.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
13.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.2.5 Becton Dickinson Recent Development13.3 Hain LifeSciences
13.3.1 Hain LifeSciences Company Details
13.3.2 Hain LifeSciences Business Overview and Its Total Revenue
13.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
13.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.3.5 Hain LifeSciences Recent Development13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
13.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
13.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development13.5 Alere, Inc
13.5.1 Alere, Inc Company Details
13.5.2 Alere, Inc Business Overview and Its Total Revenue
13.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
13.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.5.5 Alere, Inc Recent Development13.6 Roche AG
13.6.1 Roche AG Company Details
13.6.2 Roche AG Business Overview and Its Total Revenue
13.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
13.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.6.5 Roche AG Recent Development
13.7 Hologic Corporation
13.7.1 Hologic Corporation Company Details
13.7.2 Hologic Corporation Business Overview and Its Total Revenue
13.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
13.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.7.5 Hologic Corporation Recent Development
13.8 bioMerieux
13.8.1 bioMerieux Company Details
13.8.2 bioMerieux Business Overview and Its Total Revenue
13.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
13.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.8.5 bioMerieux Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
13.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.9.5 Sanofi Recent Development13.10 QIAGEN
13.10.1 QIAGEN Company Details
13.10.2 QIAGEN Business Overview and Its Total Revenue
13.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
13.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
13.10.5 QIAGEN Recent Development
13.11 Akonni Biosystems, Inc.
10.11.1 Akonni Biosystems, Inc. Company Details
10.11.2 Akonni Biosystems, Inc. Business Overview and Its Total Revenue
10.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
10.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
10.11.5 Akonni Biosystems, Inc. Recent Development
13.12 Epistem Holdings Plc
10.12.1 Epistem Holdings Plc Company Details
10.12.2 Epistem Holdings Plc Business Overview and Its Total Revenue
10.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
10.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
10.12.5 Epistem Holdings Plc Recent Development
13.13 Gen-Probe Inc.
10.13.1 Gen-Probe Inc. Company Details
10.13.2 Gen-Probe Inc. Business Overview and Its Total Revenue
10.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
10.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
10.13.5 Gen-Probe Inc. Recent Development
13.14 EIKEN Chemical
10.14.1 EIKEN Chemical Company Details
10.14.2 EIKEN Chemical Business Overview and Its Total Revenue
10.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
10.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
10.14.5 EIKEN Chemical Recent Development
13.15 Thermo Fisher Scientific, Inc
10.15.1 Thermo Fisher Scientific, Inc Company Details
10.15.2 Thermo Fisher Scientific, Inc Business Overview and Its Total Revenue
10.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
10.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020)
10.15.5 Thermo Fisher Scientific, Inc Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Tuberculosis Diagnostics and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
Table 3. Ranking of Global Top Tuberculosis Diagnostics and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Skin Testing
Table 6. Key Players of Laboratory Testing
Table 7. COVID-19 Impact Global Market: (Four Tuberculosis Diagnostics and Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Tuberculosis Diagnostics and Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Tuberculosis Diagnostics and Treatment Players to Combat Covid-19 Impact
Table 12. Global Tuberculosis Diagnostics and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2015-2020)
Table 16. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Tuberculosis Diagnostics and Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Tuberculosis Diagnostics and Treatment Players
Table 23. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Tuberculosis Diagnostics and Treatment Market Share by Players (2015-2020)
Table 25. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2019)
Table 26. Global Tuberculosis Diagnostics and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
Table 29. Date of Enter into Tuberculosis Diagnostics and Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Tuberculosis Diagnostics and Treatment Market Size Share by Type (2015-2020)
Table 33. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Tuberculosis Diagnostics and Treatment Market Size Share by Application (2015-2020)
Table 35. Global Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Tuberculosis Diagnostics and Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 39. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 41. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 45. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 47. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 51. China Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 53. China Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 57. Japan Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 59. Japan Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 63. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 69. India Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 71. India Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Tuberculosis Diagnostics and Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Tuberculosis Diagnostics and Treatment Market Share (2019-2020)
Table 75. Central & South America Tuberculosis Diagnostics and Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Tuberculosis Diagnostics and Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Tuberculosis Diagnostics and Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Tuberculosis Diagnostics and Treatment Market Share by Application (2015-2020)
Table 79. Cepheid Inc Company Details
Table 80. Cepheid Inc Business Overview
Table 81. Cepheid Inc Product
Table 82. Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 83. Cepheid Inc Recent Development
Table 84. Becton Dickinson Company Details
Table 85. Becton Dickinson Business Overview
Table 86. Becton Dickinson Product
Table 87. Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 88. Becton Dickinson Recent Development
Table 89. Hain LifeSciences Company Details
Table 90. Hain LifeSciences Business Overview
Table 91. Hain LifeSciences Product
Table 92. Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 93. Hain LifeSciences Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Product
Table 97. Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 98. Abbott Laboratories Recent Development
Table 99. Alere, Inc Company Details
Table 100. Alere, Inc Business Overview
Table 101. Alere, Inc Product
Table 102. Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 103. Alere, Inc Recent Development
Table 104. Roche AG Company Details
Table 105. Roche AG Business Overview
Table 106. Roche AG Product
Table 107. Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 108. Roche AG Recent Development
Table 109. Hologic Corporation Company Details
Table 110. Hologic Corporation Business Overview
Table 111. Hologic Corporation Product
Table 112. Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 113. Hologic Corporation Recent Development
Table 114. bioMerieux Business Overview
Table 115. bioMerieux Product
Table 116. bioMerieux Company Details
Table 117. bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 118. bioMerieux Recent Development
Table 119. Sanofi Company Details
Table 120. Sanofi Business Overview
Table 121. Sanofi Product
Table 122. Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 123. Sanofi Recent Development
Table 124. QIAGEN Company Details
Table 125. QIAGEN Business Overview
Table 126. QIAGEN Product
Table 127. QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 128. QIAGEN Recent Development
Table 129. Akonni Biosystems, Inc. Company Details
Table 130. Akonni Biosystems, Inc. Business Overview
Table 131. Akonni Biosystems, Inc. Product
Table 132. Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 133. Akonni Biosystems, Inc. Recent Development
Table 134. Epistem Holdings Plc Company Details
Table 135. Epistem Holdings Plc Business Overview
Table 136. Epistem Holdings Plc Product
Table 137. Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 138. Epistem Holdings Plc Recent Development
Table 139. Gen-Probe Inc. Company Details
Table 140. Gen-Probe Inc. Business Overview
Table 141. Gen-Probe Inc. Product
Table 142. Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 143. Gen-Probe Inc. Recent Development
Table 144. EIKEN Chemical Company Details
Table 145. EIKEN Chemical Business Overview
Table 146. EIKEN Chemical Product
Table 147. EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 148. EIKEN Chemical Recent Development
Table 149. Thermo Fisher Scientific, Inc Company Details
Table 150. Thermo Fisher Scientific, Inc Business Overview
Table 151. Thermo Fisher Scientific, Inc Product
Table 152. Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2015-2020) (Million US$)
Table 153. Thermo Fisher Scientific, Inc Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostics and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Skin Testing Features
Figure 3. Laboratory Testing Features
Figure 4. Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Tuberculosis Diagnostics and Treatment Report Years Considered
Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Tuberculosis Diagnostics and Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Tuberculosis Diagnostics and Treatment Market Share by Players in 2019
Figure 14. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics and Treatment Revenue in 2019
Figure 16. North America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Cepheid Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Cepheid Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 25. Becton Dickinson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 27. Hain LifeSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Hain LifeSciences Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 31. Alere, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Alere, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 33. Roche AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Roche AG Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 35. Hologic Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 37. bioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sanofi Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 41. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 43. Akonni Biosystems, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Akonni Biosystems, Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 45. Epistem Holdings Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Epistem Holdings Plc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 47. Gen-Probe Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Gen-Probe Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 49. EIKEN Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. EIKEN Chemical Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 51. Thermo Fisher Scientific, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
-
The Global Tuberculosis Diagnostics and Treatment Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
Global Tuberculosis Diagnostics and Treatment has a wide range of applications, including
According to the report, the Global Tuberculosis Diagnostics and Treatment Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
According to the Global Tuberculosis Diagnostics and Treatment Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
During the forecast years, the Global Tuberculosis Diagnostics and Treatment Market can thrive with a robust CAGR.
